|
Market Closed -
NSE India S.E.
07:05:10 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 172.50 INR | +2.80% |
|
+2.74% | -39.38% |
| 05-25 | Vaidya Sane Ayurved Laboratories Limited, 2026 Earnings Call, May 18, 2026 | |
| 05-17 | Vaidya Sane Ayurved Laboratories Limited Provides Earnings Guidance for the Fiscal Year 2027 | CI |
| Market Cap | 1.81B 18.91M 16.69M 15.79M 14.32M 26.85M 27.11M 189M 73.01M 927M 71.02M 69.47M 2.98B | P/E 2025 |
16.1x | P/E 2026 | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61B 16.78M 14.81M 14.01M 12.71M 23.82M 24.05M 168M 64.77M 822M 63M 61.63M 2.65B | EV / Sales 2025 |
0.92x | EV / Sales 2026 | 1.45x |
| Free-Float |
98.94% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: Vaidya Sane Ayurved Laboratories Limited
| 1 day | +2.80% | ||
| 1 week | +2.74% | ||
| Current month | +2.07% | ||
| 1 month | +1.80% | ||
| 3 months | -1.65% | ||
| 6 months | -1.43% | ||
| Current year | -39.38% |
| 1 week | 160 |  | 175 |
| 1 month | 147 | | 176.25 |
| Current year | 147 | | 294 |
| 1 year | 147 | | 335 |
| 3 years | 81.1 | | 335 |
| 5 years | 81.1 | | 376.95 |
| 10 years | 81.1 | | 376.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rohit Sane
CEO | Chief Executive Officer | 48 | 1999-04-05 |
Narendra Pawar
DFI | Director of Finance/CFO | - | 2024-05-26 |
Gurudatta Amin
CTO | Chief Tech/Sci/R&D Officer | 42 | 2014-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Rohit Sane
BRD | Director/Board Member | 48 | 1999-04-05 |
| Director/Board Member | 44 | 2021-08-31 | |
| Director/Board Member | 59 | 2021-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.80% | +2.74% | -38.39% | -44.35% | 18.4M | |
| +0.09% | +3.17% | +55.63% | +120.60% | 1,056B | |
| +0.16% | -0.52% | +44.42% | +72.59% | 645B | |
| +0.36% | -0.41% | +14.02% | +78.08% | 465B | |
| -1.69% | -0.79% | +75.03% | +43.25% | 368B | |
| -0.06% | -3.88% | +34.32% | +40.74% | 335B | |
| -0.79% | +2.01% | +19.82% | +28.48% | 275B | |
| -1.19% | -1.21% | +9.82% | +12.15% | 255B | |
| -0.01% | +4.38% | +50.21% | +59.17% | 229B | |
| -0.32% | -0.42% | +35.79% | +103.41% | 188B | |
| Average | -0.01% | +0.10% | +30.07% | +51.41% | 381.58B | |
| Weighted average by Cap. | -0.19% | +0.30% | +41.72% | +74.41% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 898M 9.36M 8.26M 7.82M 7.09M 13.29M 13.42M 93.79M 36.15M 459M 35.16M 34.39M 1.48B | 1.07B 11.14M 9.83M 9.3M 8.44M 15.82M 15.97M 112M 43.01M 546M 41.83M 40.92M 1.76B |
| Net income | 71.36M 744K 656K 621K 563K 1.06M 1.07M 7.45M 2.87M 36.44M 2.79M 2.73M 117M | 89.87M 937K 826K 782K 709K 1.33M 1.34M 9.38M 3.62M 45.89M 3.52M 3.44M 148M |
| Net Debt | -159M -1.65M -1.46M -1.38M -1.25M -2.35M -2.37M -16.55M -6.38M -80.97M -6.2M -6.07M -261M | -205M -2.13M -1.88M -1.78M -1.62M -3.03M -3.06M -21.38M -8.24M -105M -8.01M -7.84M -337M |
Employees
413
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | ₹172.50 | +2.80% | 48,000 |
| 26-09-29 | ₹167.80 | +1.70% | 18,800 |
| 26-09-28 | ₹165.00 | +2.33% | 19,600 |
| 26-09-25 | ₹161.25 | -4.02% | 5,200 |
| 26-09-24 | ₹168.00 | -2.04% | 2,400 |
- Stock Market
- Stocks
- MADHAVBAUG Stock
Select your edition
All financial news and data tailored to specific country editions
